233 related articles for article (PubMed ID: 9540780)
1. [Prevention of the extension of distal deep venous thrombosis. A randomized controlled trial with a 6-month follow-up].
Belcaro G; Laurora G; Cesarone MR; De Sanctis MT; Incandela L; Dugall M; Mezzanotte L
Minerva Med; 1997 Dec; 88(12):507-14. PubMed ID: 9540780
[TBL] [Abstract][Full Text] [Related]
2. Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study.
Belcaro G; Nicolaides AN; Errichi BM; Cesarone MR; De Sanctis MT; Incandela L; Venniker R
Angiology; 1999 Jul; 50(7):523-9. PubMed ID: 10431991
[TBL] [Abstract][Full Text] [Related]
3. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.
Belcaro G; Nicolaides AN; Cesarone MR; Laurora G; De Sanctis MT; Incandela L; Barsotti A; Corsi M; Vasdekis S; Christopoulos D; Lennox A; Malouf M
Angiology; 1999 Oct; 50(10):781-7. PubMed ID: 10535716
[TBL] [Abstract][Full Text] [Related]
4. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
[TBL] [Abstract][Full Text] [Related]
6. Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin.
Partsch H; Blättler W
J Vasc Surg; 2000 Nov; 32(5):861-9. PubMed ID: 11054217
[TBL] [Abstract][Full Text] [Related]
7. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis.
Gonzalez-Fajardo JA; Arreba E; Castrodeza J; Perez JL; Fernandez L; Agundez I; Mateo AM; Carrera S; Gutiérrez V; Vaquero C
J Vasc Surg; 1999 Aug; 30(2):283-92. PubMed ID: 10436448
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of 20 pregnant women with venous thromboembolic disease].
Sun P; Dong DN
Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):911-6. PubMed ID: 22333281
[TBL] [Abstract][Full Text] [Related]
9. Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis.
Fiessinger JN; Lopez-Fernandez M; Gatterer E; Granqvist S; Kher A; Olsson CG; Söderberg K
Thromb Haemost; 1996 Aug; 76(2):195-9. PubMed ID: 8865530
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement? Fraxiparine Oral Anticoagulant Study Group.
Hamulyák K; Lensing AW; van der Meer J; Smid WM; van Ooy A; Hoek JA
Thromb Haemost; 1995 Dec; 74(6):1428-31. PubMed ID: 8772214
[TBL] [Abstract][Full Text] [Related]
11. [Compression therapy in deep venous thrombosis].
Manganaro A; Buda D; Ando G; Consolo F
Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):57-60. PubMed ID: 11253342
[TBL] [Abstract][Full Text] [Related]
12. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
13. Duplex screening as a method of quality assurance of perioperative thromboembolism prophylaxis.
Van Den Berg E; Bathgate B; Panagakos E; Lambrechts R; Hani M; Meissner A; Schröder M
Int Angiol; 1999 Sep; 18(3):210-9. PubMed ID: 10688420
[TBL] [Abstract][Full Text] [Related]
14. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
15. Therapy of deep vein thrombosis.
Turpie AG
Herz; 1989 Dec; 14(6):341-7. PubMed ID: 2695442
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Ardeparin Arthroplasty Study Group.
Heit JA; Berkowitz SD; Bona R; Cabanas V; Corson JD; Elliott CG; Lyons R
Thromb Haemost; 1997 Jan; 77(1):32-8. PubMed ID: 9031445
[TBL] [Abstract][Full Text] [Related]
17. Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once- or twice-daily low-molecular-weight heparin.
Partsch H; Kechavarz B; Mostbeck A; Köhn H; Lipp C
J Vasc Surg; 1996 Nov; 24(5):774-82. PubMed ID: 8918323
[TBL] [Abstract][Full Text] [Related]
18. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
[TBL] [Abstract][Full Text] [Related]
19. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
Delis KT; Hunt N; Strachan RK; Nicolaides AN
Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
[TBL] [Abstract][Full Text] [Related]
20. [Deep venous thrombosis--treatment].
Fries R; Böhm M
Dtsch Med Wochenschr; 2003 May; 128(18):999-1002. PubMed ID: 12721879
[No Abstract] [Full Text] [Related]
[Next] [New Search]
